During the past 20 years, important progress has been made in our understanding of the molecular pathogenesis of lung cancer, whose malignant transformation has been demonstrated to result from the accumulation of genetic aberrations such as in EGFR [31], KRAS [32], and ALK [33]. This evidence concerns the gene ALK and lung carcinoma.